PacBio
PacBio's mission is to enable the potential of genomics to improve human health by creating the world’s most advanced sequencing systems to provide the most complete and accurate view of genomes, transcriptomes and epigenomes.
Latest Content
    
        Industry Insight
    
                
        
    
    
            How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing
    Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.
        
    
        Product News
    
                
        
    
    
            PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing To Help Advance Rare Disease Diagnostics
    PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics. 
        
    
        Product News
    
                
        
    
    
            PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
    PacBio (NASDAQ: PACB), announced the Vega™ system, the company’s first benchtop long-read sequencing platform.
        
    
        Product News
    
                
        
    
    
            PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to Less Than $500
    New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT cell, improves methylation calling, and expands support for multiomics.
        
    
        Product News
    
                
        
    
    
            PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
    PacBio (Nasdaq: PACB), announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program.
        
    
        Product News
    
                
        
    
    
            Revio To Power Research in Male Infertility and Rare Disease at Münster University Hospital
    Highly accurate long-read sequencing data from Revio will support Germany’s national genome Initiative and provide data to the international male infertility consortium.
        
    
        Product News
    
                
        
    
    
            Novogene To Power Cancer, Rare Disease, and Environmental Research With PacBio Sequencing
    Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions.
        
    
        Industry Insight
    
                
        
    
    
            Sequencing Life To Conserve Biodiversity
    Neil Ward tells us about the role that genomics can play in conserving biodiversity and how innovative technologies such as HiFi sequencing are helping biodiversity projects.
        
    
        Product News
    
                
        
    
    
            Estonia National Biobank Selects PacBio To Sequence 10,000 Whole Genomes
    HiFi data generated on the Revioä system will support the EU and Estonian government-funded Center for Personalized Medicine and unlock discoveries across cardiology, mental and reproductive health, drug response, cancer research and rare diseases.
        
    
        Product News
    
                
        
    
    
            PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
    New library preparation solutions offer never before achieved scale for the Revio™ sequencing system.
        
            Advertisement